Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Gorf79on Jul 03, 2022 6:52am
105 Views
Post# 34797841

RE:Rough Valuation ——— MM & AP

RE:Rough Valuation ——— MM & APYou boys are slow on the draw so I ran my own calcs.

Using an average industry multiple of the past 5 years of biotech ( 17 x) and an average penetration of 45% over 5 years I have a SP of $28.66.

That assumes a 50% GM and a selling price of 25K for both SAMI and DIMI. Some other minor assumptions as well.......Those are a bit of a guess but got some insight from some reporting on Braun and Da Vita....

Anyhow, there is mine.


<< Previous
Bullboard Posts
Next >>